Correlation Between Amicus Therapeutics and FibroGen

Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and FibroGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and FibroGen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amicus Therapeutics and FibroGen, you can compare the effects of market volatilities on Amicus Therapeutics and FibroGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of FibroGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and FibroGen.

Diversification Opportunities for Amicus Therapeutics and FibroGen

0.09

Correlation Coefficient

Amicus Therapeutics  FibroGen

Significant diversification

The 3 months correlation between Amicus and FibroGen is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and FibroGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroGen and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with FibroGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroGen has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and FibroGen go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and FibroGen

Given the investment horizon of 90 days Amicus Therapeutics is expected to under-perform the FibroGen. But the stock apears to be less risky and, when comparing its historical volatility, Amicus Therapeutics is 5.63 times less risky than FibroGen. The stock trades about -0.05 of its potential returns per unit of risk. The FibroGen is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  40.00  in FibroGen on December 20, 2024 and sell it today you would lose (4.00) from holding FibroGen or give up 10.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Amicus Therapeutics  vs.  FibroGen

Amicus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Amicus Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

FibroGen

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in FibroGen are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, FibroGen displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Amicus Therapeutics and FibroGen

The main advantage of trading using opposite Amicus Therapeutics and FibroGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, FibroGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will offset losses from the drop in FibroGen's long position.

The idea behind Amicus Therapeutics and FibroGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.